Opinion in Germany

Published within

« | ... | 99 | 100 | 101 | 102 | 103 | 104 | 105 | 106 | 107 | ... | » »|

Type Product title / description Pub Price
Expert View
Expert View

New food review: vegetables work themselves into a lather with new foam offerings

Creative developments in the vegetable category headline this month's summary of food industry launches. The popularity of gastronomic experimentation continues unabated, with a new range of vegetable foams being launched in France. Meanwhile, lettuce leaves are replacing traditional bread-based wraps, and beetroot has been given an overhaul with a bold chocolate and mint flavored offering.

Published By Datamonitor
05 Apr 2012
Expert View
Expert View

PLA seasonal innovations: chocolate Easter treats from around the globe

The Easter Bunny has been busy this spring, with innovative chocolate products taking pride of place on supermarket shelves around the world. PLA has found that there is something to make everyone smile, from a traditional Christian chocolate cross and royalty-themed chocolate ducks, to real egg shells filled with praline, decorate your own egg kits, and a cocktail egg from Brazil.

Published By Datamonitor
05 Apr 2012
ResearchWire
ResearchWire

PLA Innovation of the Week: a "liquid free" energy shot

Published By Datamonitor
20 Apr 2012
Expert View
Expert View

AAN 2012: Novartis presents new data in an attempt to boost confidence in long-term use of Gilenya

In keeping with American Academy of Neurology meetings of recent years, multiple sclerosis once again dominated proceedings at AAN 2012. Novartis used the platform to present new data from the extension FREEDOMS II trial to support the long-term use of Gilenya, and provided Phase II results for siponimod in relapse remitting multiple sclerosis.

Published By Datamonitor
03 May 2012
Expert View
Expert View

AAN 2012: research shows value of early disease identification, but caution in treatment is advised

At AAN 2012, Merck Serono presented data from a long-term study showing that early Rebif treatment significantly reduced the clinical progression of multiple sclerosis. However, early intervention should be used cautiously to avoid unnecessary treatment.

Published By Datamonitor
03 May 2012
ResearchWire
ResearchWire

PLA Innovation of the Week: a new vodka product with a built-in aerator

Published By Datamonitor
10 May 2012
Expert View
Expert View

New drinks review: QR branding sees wine embrace the smartphone era

The emergence of QR codes in line with growing consumer take-up of smartphone technology is offering diverse marketing and branding opportunities to consumer goods companies, as evidenced by the sparkling wine launch that headlines this month's rundown of drinks innovations. Meanwhile, new flavors are emerging in the gin segment and novel formats are being explored for liqueurs and bottled water.

Published By Datamonitor
14 May 2012
Expert View
Expert View

New food review: energy products take a cue from medicine with capsule innovation

A new energizing powder sold in capsules and designed to be sucked through a straw rather than consumed as a drink or a shot is among the innovations to feature in this month's roundup of the latest food industry launches. In other news, cake mixes have taken a decorative turn, and a rival to peanut butter has hit stores in the US.

Published By Datamonitor
14 May 2012
Expert View
Expert View

New personal care review: antibacterial silver finds new home in nail varnish

In this month's run-through of the latest launches from the personal care industry, an antibacterial silver ingredient is part of a novel formulation in the nail varnish category. In other news, a US company could court controversy with the launch of a lipstick for babies, while a soap product takes its cues from confectionery in a bid to enhance its indulgence appeal.

Published By Datamonitor
14 May 2012
Expert View
Expert View

APA 2012: standout schizophrenia and bipolar depression data for Latuda steal the show

New clinical data were presented at APA 2012 that showed that Latuda is effective as an adjunctive treatment for bipolar depression and may possess a procognitive effect in schizophrenia patients. These findings set Latuda apart from the competition and may allow the drug to shine in a fiercely competitive antipsychotics market.

Published By Datamonitor
15 May 2012

« | ... | 99 | 100 | 101 | 102 | 103 | 104 | 105 | 106 | 107 | ... | » »|

No help is available.